Search Results - "Prasad, Rammani"

Crisaborole-Enthused Glycerosomal Gel for an Augmented Skin Permeation by Singh, Ragini, Singh, Anshu, Srivastava, Dipti, Fatima, Zeeshan, Prasad, Rammani

“…Crisaborole (CB), a boron-based compound, is the first topical PDE4 inhibitor to be approved by the US Food and Drug Administration (2016) for the treatment of…”
Get more information

Crisaborole Loaded Nanoemulgel for the Mitigation of Atopic Dermatitis in Mice Model by Kataria, Shubham, Roy, Supriya, Chaurasia, Mohini, Awasthi, Himani, Fatima, Zeeshan, Prasad, Rammani, Srivastava, Dipti

“…The present work is aimed to formulate nanoemulgel of crisaborole (CB) and evaluate its effectiveness against 2,4-Di-nitrochlorobenzene induced (DNCB) atopic…”
Get full text

Glibenclamide-malonic acid cocrystal with an enhanced solubility and bioavailability by Srivastava, Dipti, Fatima, Zeeshan, Kaur, Chanchal Deep, Mishra, Anjali, Nashik, Sanap Sachin, Rizvi, Dilshad A., Prasad, Rammani

“…The objective of the work is to enhance the solubility, dissolution, and pharmacokinetic properties of glibenclamide (GLB) via cocrystallization technique…”
Get full text

Box–behnken design based optimized Quercetin nano formulation for palliative treatment of atopic dermatitis by Singh, Anshu, Biswas, Arpon, Choudhari, Manisha, Roy, Supriya, Prasad, Rammani, Ahmad, Shariq, Rizvi, Dilshad Ali, Nandy, Abhishek, Singh, Aditi, Mishra, Anjali, Srivastava, Dipti, Fatima, Zeeshan

“…[Display omitted]…”
Get full text

Furosemide - Soluplus® Solid Dispersion: Development and Characterization by Prasad, Rammani, Radhakrishnan, Praveen, Singh, Sandeep K, Verma, Priya R P

“…Recent patents reveal that Soluplus® has proved to be a promising excipient that modulates dissolution characteristics of many active pharmaceutical…”
Get more information